E. Soravia

688 citations
7 papers · 584 indexed · h-index 7
Topics
Protease and Inhibitor Mechanisms (4 papers)Signaling Pathways in Disease (2 papers)Peptidase Inhibition and Analysis (2 papers)

In The Last Decade

E. Soravia

7 papers receiving 565 citations

Peers

E. Soravia
Comparison fields: 5 of 77
  • Molecular Biology 339
  • Microbiology 167
  • Cancer Research 149
  • Physiology 102
  • Immunology 98
Replace Mara Fortunato with:
Mara Fortunato United Kingdom
Daniel P. Kestler United States
Silvia Jordans Germany
Liqing Xiao United States
G E Conner United States
Randall K. Walker United States
Susann Busch Sweden
C M Jones United Kingdom
Debra M. MacIvor United States
Zahangir Khaled United States
E. Soravia relative to Mara Fortunato United Kingdom Mara Fortunato's profile →
Citations per field
00.5×4.1×
Mara Fortunato · 1×
Citations per year

Countries citing papers authored by E. Soravia

Since Specialization
Citations

This map shows the geographic impact of E. Soravia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Soravia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Soravia more than expected).

Fields of papers citing papers by E. Soravia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Soravia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Soravia. The network helps show where E. Soravia may publish in the future.

Co-authorship network of co-authors of E. Soravia

This figure shows the co-authorship network connecting the top 25 collaborators of E. Soravia. A scholar is included among the top collaborators of E. Soravia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Soravia. E. Soravia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 63
2
A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene.
65
3 51
4 11
5 182
6 102
7 110

About E. Soravia

E. Soravia is a scholar working on Cancer Research, Immunology and Allergy and Microbiology, having authored 7 papers that have together received 584 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (4 papers), Signaling Pathways in Disease (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Microbiology (167 citations), Cancer Research (149 citations) and Hematology (68 citations). E. Soravia has collaborated with scholars based in United States, Italy and Denmark. Frequent co-authors include Michael Zasloff, G. Martini, Richard L. Proia, Francesco Blasi, Kristian Helin, Pasquale De Luca, Gerald Zon, Neil D. Goldman, Lisbeth Birk Møller and Maria Vittoria Cubellis. Their work appears in journals such as Journal of Biological Chemistry, Blood and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026